Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Amortizatization of Intangibles (2019 - 2025)

Historic Amortizatization of Intangibles for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $6.0 million.

  • Harmony Biosciences Holdings' Amortizatization of Intangibles changed 0.0% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year change of 0.42%. This contributed to the annual value of $23.8 million for FY2024, which is 0.0% changed from last year.
  • Harmony Biosciences Holdings' Amortizatization of Intangibles amounted to $6.0 million in Q3 2025, which was down 0.0% from $6.0 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Amortizatization of Intangibles registered a high of $6.0 million during Q3 2023, and its lowest value of $4.6 million during Q3 2021.
  • For the 5-year period, Harmony Biosciences Holdings' Amortizatization of Intangibles averaged around $5.6 million, with its median value being $6.0 million (2022).
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Amortizatization of Intangibles soared by 15638.3% in 2021, and later decreased by 1.68% in 2024.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Amortizatization of Intangibles stood at $4.6 million in 2021, then increased by 28.39% to $6.0 million in 2022, then changed by 0.0% to $6.0 million in 2023, then increased by 0.02% to $6.0 million in 2024, then fell by 0.02% to $6.0 million in 2025.
  • Its last three reported values are $6.0 million in Q3 2025, $6.0 million for Q2 2025, and $6.0 million during Q1 2025.